ABVC BioPharma, Inc.: 10-Q/A filed 2011-09-08

Name: ABVC BioPharma, Inc.: 10-Q/A filed 2011-09-08
Creator: ABVC BioPharma, Inc.

What ABVC BioPharma, Inc. reported in its quarterly report amendment filed 2011-09-08 (fiscal Q3 2011): 22 published measures, 58 facts as tagged in accession 0001173313-11-000048.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form: 10-Q/A (quarterly report amendment)
Filed: 2011-09-08
Fiscal period: fiscal Q3 2011
Accession: 0001173313-11-000048 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ABVC BioPharma, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2011-06-30	392,590	USD
At 2010-09-30	293,935	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2011-06-30	-1,365,899	USD
At 2010-09-30	-2,993,817	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2011-06-30	73,346	USD
At 2010-09-30	2,814	USD
At 2010-06-30	14,020	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	-815,412	USD	91
2010-10-01 to 2011-06-30	-756,617	USD	273
2010-04-01 to 2010-06-30	-209,313	USD	91
2009-10-01 to 2010-06-30	-1,523,819	USD	273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2010-10-01 to 2011-06-30	-1,292,609	USD	273
2009-10-01 to 2010-06-30	-876,880	USD	273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2010-10-01 to 2011-06-30	3,190	USD	273
2010-04-01 to 2010-06-30	2,829	USD	91
2009-10-01 to 2010-06-30	13,714	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2010-10-01 to 2011-06-30	1,400,897	USD	273
2009-10-01 to 2010-06-30	893,616	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2010-10-01 to 2011-06-30	-37,757	USD	273
2009-10-01 to 2010-06-30	-2,716	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2011-06-30	-28,088,016	USD
At 2010-09-30	-25,764,937	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	10,658,506	shares	91
2010-10-01 to 2011-06-30	9,248,566	shares	273
2010-04-01 to 2010-06-30	6,582,137	shares	91
2009-10-01 to 2010-06-30	6,582,137	shares	273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2011-06-30	63,439	USD
At 2010-09-30	41,925	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	-773,355	USD	91
2010-10-01 to 2011-06-30	-1,470,248	USD	273
2010-04-01 to 2010-06-30	-338,899	USD	91
2009-10-01 to 2010-06-30	-1,547,326	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2011-06-30	119,675	USD
At 2010-09-30	33,151	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	-42,557	USD	91
2010-10-01 to 2011-06-30	-160,498	USD	273
2010-04-01 to 2010-06-30	-61,969	USD	91
2009-10-01 to 2010-06-30	-168,048	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2011-06-30	1,758,489	USD
At 2010-09-30	3,287,752	USD

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2011-06-30	10,658,506	shares
At 2010-09-30	6,582,137	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2011-06-30	26,711,456	USD
At 2010-09-30	22,738,182	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2011-06-30	149,498	USD
At 2010-09-30	116,681	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2011-06-30	-86,059	USD
At 2010-09-30	-74,756	USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	-1,168,850	USD	91
2010-10-01 to 2011-06-30	-2,323,079	USD	273
2010-04-01 to 2010-06-30	-253,662	USD	91
2009-10-01 to 2010-06-30	-2,653,699	USD	273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	773,355	USD	91
2010-10-01 to 2011-06-30	1,473,438	USD	273
2010-04-01 to 2010-06-30	341,728	USD	91
2009-10-01 to 2010-06-30	1,561,040	USD	273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2010-10-01 to 2011-06-30	-540,662	USD	273
2009-10-01 to 2010-06-30	-98,911	USD	273

Inspect the source

Entity: ABVC BioPharma, Inc. / CIK 0001173313
Captured: 2026-09-19T11:16:49.109Z
SEC response SHA-256: a42942c118304cb578665c27ca73d827a17f370dd57a31742c919c9b41b25c34

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001173313.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))